Sholevar Roxanne, Peteet John, Sanders Justin, Beaussant Yvan
Department of Psychosocial Oncology and Palliative Care, The Dana-Farber Cancer Institute, Boston, MA, USA.
Department of Psychosocial Oncology and Palliative Care, Harvard Medical School, Boston, MA, USA.
Palliat Support Care. 2023 Dec;21(6):967-972. doi: 10.1017/S1478951523001475.
Psychedelic-assisted therapies (PAT) are emerging as a promising treatment for psycho-existential distress in patients with serious illness. A recent qualitative analysis of perspectives of 17 experts in serious illness care and/or PAT research identified divergent views on the therapeutic potential and safety of PAT in patients with serious illness. This paper further analyzes the factors that may influence these views.
To identify factors underlying the attitudes of experts in serious illness care and/or PAT toward PAT and its potential role in serious illness care.
Semi-structured interviews of 17 experts in serious illness care and/or PAT from the United States and Canada were analyzed to identify factors cited as influencing their views on PAT.
Five factors were identified as influencing experts' attitudes toward PAT: perception of unmet need, knowledge of empirical studies of PAT, personal experience with psychedelics, professional background, and age/generation. In addition, an integrative theme emerged from the analysis, namely PAT's disruptive potential at 4 levels relevant to serious illness care: patient's experience of self, illness, and death; relationships with loved ones and health-care providers; existing clinical models of serious illness care; and societal attitudes toward death. Whether this disruptive potential was viewed as a therapeutic opportunity, or an undue risk, was central in influencing experts' level of support. Experts' perception of this disruptive potential was directly influenced by the 5 identified factors.
Points of disruption potentially invoked by PAT in serious illness care highlight important practical and philosophical considerations when working to integrate PAT into serious illness care delivery in a safe and effective way.
迷幻剂辅助疗法(PAT)正在成为治疗重症患者心理存在困扰的一种有前景的疗法。最近一项对17名重症护理专家和/或PAT研究专家观点的定性分析发现,对于PAT在重症患者中的治疗潜力和安全性存在不同观点。本文进一步分析可能影响这些观点的因素。
确定重症护理专家和/或PAT专家对PAT的态度及其在重症护理中潜在作用的潜在因素。
对来自美国和加拿大的17名重症护理专家和/或PAT专家进行半结构化访谈,分析其中提到的影响他们对PAT看法的因素。
确定了五个影响专家对PAT态度的因素:对未满足需求的认知、对PAT实证研究的了解、迷幻剂个人体验、专业背景以及年龄/代际。此外,分析中出现了一个综合主题,即PAT在与重症护理相关的四个层面具有破坏潜力:患者对自我、疾病和死亡的体验;与亲人及医疗服务提供者的关系;现有的重症护理临床模式;以及社会对死亡的态度。这种破坏潜力被视为治疗机会还是不当风险,是影响专家支持程度的关键。专家对这种破坏潜力的认知直接受到所确定的五个因素的影响。
PAT在重症护理中可能引发的破坏点突出了在努力以安全有效的方式将PAT纳入重症护理时重要的实践和哲学考量。